The San Francisco Giants are making a bold move that could either be a stroke of genius or a risky gamble. They've just signed Michael Fulmer to a minor league deal, a decision that has fans and analysts alike scratching their heads. But here's where it gets interesting: Fulmer, a 33-year-old right-hander with a history of both major league success and devastating injuries, is far from a sure bet. Could this be the comeback story of the season, or is it a desperate attempt to fill a gaping hole in the Giants' bullpen?
Fulmer's journey has been nothing short of a rollercoaster. Once a cornerstone of the Detroit Tigers' rotation, he snagged the American League Rookie of the Year title in 2016. But then, as if fate had it out for him, Tommy John surgery sidelined him for the entire 2019 season. When he returned, he struggled to find his footing, eventually settling into a bullpen role. From 2021 to 2023, he was a reliable reliever, posting a 3.55 ERA and striking out 24.6% of batters. But just as he seemed to be back on track, another injury—this time a revision surgery on his ulnar collateral ligament—cost him the 2024 season. Last year, he bounced around the minors, with brief stints in the big leagues for the Red Sox and Cubs, but never quite reclaimed his former glory.
And this is the part most people miss: The Giants' bullpen is in dire straits. After trading away key relievers like Tyler Rogers and Camilo Doval, and with Randy Rodríguez out due to Tommy John surgery, the team has been left scrambling. Their only moves so far have been low-risk, high-reward signings of injury-prone players like Sam Hentges and Jason Foley. Fulmer, alongside Gregory Santos, now joins this group of experienced non-roster invitees, hoping to pitch his way back into a regular major league role. But can he stay healthy long enough to make an impact?
Meanwhile, the Giants have also added outfielder Jared Oliva to the mix. At 30, Oliva hasn’t exactly set the world on fire in his limited major league appearances, batting just .179 over 26 games with the Pirates. However, he’s a speedster, stealing 57 bases last year in the minors, and could provide valuable depth if the Giants' regular outfield—Harrison Bader, Jung Hoo Lee, and Heliot Ramos—faces injuries or slumps. With a crowded outfield picture that includes Jerar Encarnación, Drew Gilbert, and Luis Matos, Oliva will need to stand out to secure a bench spot.
But here's the controversial question: Are the Giants setting themselves up for success, or are they simply patching holes with players past their prime? Fulmer’s injury history is a red flag, and Oliva’s major league track record is underwhelming. Yet, both players bring unique skills to the table—Fulmer’s strikeout potential and Oliva’s speed—that could pay dividends if everything falls into place. Is this a smart, low-risk strategy, or are the Giants grasping at straws?
What do you think? Is this a calculated risk worth taking, or are the Giants fooling themselves? Let us know in the comments—we want to hear your take on this intriguing offseason move!
